# PharmaSight™ Public Analog Discovery Registry

## Purpose
This document serves as a **publicly accessible registry** of pharmaceutical compound analogs discovered and compiled through the PharmaSight™ platform. Publication of this registry establishes **prior art** and **intellectual property rights** for the discoverer.

## Legal Notice
All compounds listed in this registry are claimed as discoveries by the PharmaSight™ research team. This public disclosure establishes prior art and may be used to support patent applications or defend against third-party patent claims.

**Registry Established:** 2025-11-10
**Last Updated:** 2025-11-10 19:43:46 UTC
**Total Discovery Sessions:** 12
**Total Analog Discoveries:** 119

---

## Summary Statistics

| Parent Compound | Sessions | Total Analogs | Patent-Free | High Value |
|-----------------|----------|---------------|-------------|------------|
| Ketamine        | 2        | 18            | 16          | 18         |
| Psilocybin      | 1        | 3             | 3           | 2          |
| MDMA            | 1        | 15            | 15          | 15         |
| LSD             | 1        | 10            | 10          | 10         |
| Fentanyl        | 1        | 12            | 12          | 12         |
| Morphine        | 1        | 15            | 15          | 15         |
| Alprazolam      | 1        | 12            | 12          | 12         |
| Cocaine         | 1        | 10            | 10          | 10         |
| Methamphetamine | 1        | 12            | 12          | 12         |
| Ibogaine        | 1        | 12            | 12          | 12         |

## Discovery Methods
- RDKit-based Computational Generation
- Database Compilation & Literature Review
- AI-driven Structure Modification
- Patent Landscape Analysis

## Key Transformations Applied
- Add Fluorine (improved metabolic stability)
- Replace Hydrogen With Halogen
- Add Methoxy Group (enhanced bioavailability)
- Add Methyl Group
- Ring Expansion
- Extend Carbon Chain
- Add Hydroxyl

## Value Distribution
- Very High Potential ($25M-$50M): 95 analogs
- High Potential ($10M-$25M): 18 analogs
- Moderate Potential ($5M-$10M): 6 analogs

## Patent Status Distribution
- Patent-Free (Novel): 107 analogs
- Patent Pending: 5 analogs
- Patented: 3 analogs
- Patent Expired: 4 analogs

---

*This registry is maintained by PharmaSight™ research team.*
*For full analog details, access the platform's Analog/IP module.*
